IL10 and tuberculosis: Taken together, these analyses indicated that TBDM individuals had higher levels of circulating pro-inflammatory mediators compared to TB individuals at baseline, and this systemic hyper-inflammatory state persisted through the course of TB treatment with a temporal shift in relative IL-10 levels.